Following its sudden withdrawal of strict Covid-19 containment measures, the Chinese government has no choice but to import mRNA vaccines and antiviral medications if it hopes to limit a looming surge in Covid-19-related deaths, according to two US-based experts.
Without lockdowns or other mitigation measures, and in the absence of mRNA vaccines, China can expect as many as 500,000 Covid-related deaths by April of next year, said Ali Mokdad, a professor at the University of Washington’s Institute for Health Metrics and Evaluation.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
